About Resolys Bio
Resolys Bio is a private company based in Delanson, New York. It has reported $250,000 raised in two offerings on Form D since May 2016. Its chief executive is Richard Sandberg.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 7, 2023 | Jun 21, 2023 | $50,000of $5.0M target | 1 | $50,000 | EquityRule 504 | Form D ↗ |
| Sep 11, 2017 | May 19, 2016amended Sep 25, 2017 | $200,000of $6.0M target | 1 | $200K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, two offerings | $250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Resolys Bio's Form D filed Jun 21, 2023.
DM
Damian Marron
Member of Board of Directors
TH
Thomas Hatch
Member of Board of Directors
MB
McKay Belk
Member of Board of Directors
RS
Richard Sandberg
Chief Executive Officer
JM
John McMichael
Member of Board of Directors
SH
Stephen Hill
Member of Board of Directors
Earlier filings also listed Jeffrey Eckmann (director, last listed Sep 2017) and James Tobin (director, last listed Sep 2017).